These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2737813)

  • 1. Arachidonic acid metabolites in Behçet's disease.
    Bozkurt M; Gürer MA; Gülekon A; Keskin N; Ercan S
    Int J Dermatol; 1989 Mar; 28(2):141-2. PubMed ID: 2737813
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease.
    Oztas MO; Onder M; Gurer MA; Bukan N; Sancak B
    Clin Exp Dermatol; 2005 Jan; 30(1):61-3. PubMed ID: 15663506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased IL-1β levels are associated with an imbalance of "oxidant/antioxidant" status during Behçet's disease.
    Chekaoui A; Lahmar K; Belguendouz H; Mazari F; Terahi M; Hakem D; Youinou P; Touil-Boukoffa C
    Eur Cytokine Netw; 2018 Sep; 29(3):95-102. PubMed ID: 30547891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum leptin concentration is increased in patients with Behçet's syndrome and is correlated with disease activity.
    Evereklioglu C; Inalöz HS; Kirtak N; Doganay S; Bülbül M; Ozerol E; Er H; Ozbek E
    Br J Dermatol; 2002 Aug; 147(2):331-6. PubMed ID: 12174107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum prolactin levels in Behçet's disease. Is there a relationship between Behcet's disease and prolactin as in other autoimmune diseases?
    Avci A; Avci D
    Acta Dermatovenerol Croat; 2013; 21(1):52-3. PubMed ID: 23683488
    [No Abstract]   [Full Text] [Related]  

  • 6. [Plasma coagulation and fibrinolysis parameters in patients with vascular Behçet's disease, and analysis of the multimeric structure of von Willebrand factor (vWF)].
    Kagawa H; Okubo S
    Ryumachi; 1993 Oct; 33(5):416-23. PubMed ID: 8256164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum leptin levels in patients with ocular and nonocular Behçet's disease.
    Yalçindağ FN; Kisa U; Batioğlu F; Yalçindağ A; Ozdemir O; Cağlayan O
    Mediators Inflamm; 2007; 2007():31986. PubMed ID: 17641728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of leptin level and Ob gene polymorphism in patients with Behcet's disease.
    Okudan N; Acar H; Gökbel H; Mevlitoğlu I; Sari F
    Arch Dermatol Res; 2006 Aug; 298(3):127-30. PubMed ID: 16786343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sialic acid value in Behcet's disease].
    Hatano M; Obara Y; Miyashita H; Sase Y
    Nihon Ganka Kiyo; 1971 Nov; 22(11):952-3. PubMed ID: 5169202
    [No Abstract]   [Full Text] [Related]  

  • 10. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
    Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
    Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum E-selectin and beta 2-microglobulin levels in Behçet's disease.
    Karakuzu A; Aktaş A; Akçay F
    J Int Med Res; 2002; 30(1):85-8. PubMed ID: 11921504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Von Willebrand factor in Behçet's syndrome.
    Yazici H; Hekim N; Ozbakir F; Yurdakul S; Tüzün Y; Pazarli H; Müftüoğlu A
    J Rheumatol; 1987 Apr; 14(2):305-6. PubMed ID: 3496454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Could be serum uric acid a risk factor for thrombosis and/or uveitis in Behcet's disease?
    Atıl A; Deniz A
    Vascular; 2018 Aug; 26(4):378-386. PubMed ID: 29360007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities of T-cell subsets in Behçet's syndrome.
    Lim SD; Haw CR; Kim NI; Fusaro RM
    Arch Dermatol; 1983 Apr; 119(4):307-10. PubMed ID: 6220679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma osteopontin levels in patients with Behcet's disease and psoriasis.
    Erturkler E; Cıcek D; Kaman D; Ozdogan S; Bakar Dertlıoglu S
    Eur J Dermatol; 2011; 21(2):203-8. PubMed ID: 21489910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemagglutination in Behcet's disease and other diseases. Its significance in diagnosis].
    UJIHARA S; KOGURE M
    Rinsho Ganka; 1962 Mar; 16():305-8. PubMed ID: 13923624
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-phagocytic beta-glucuronidase release in Behçet's disease.
    Takeuchi A; Kobayashi K; Mori M; Hashimoto A
    Clin Exp Rheumatol; 1986; 4(1):3-7. PubMed ID: 3698358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal polymorphonuclear leucocyte chemotaxis in Behçet's syndrome.
    James DW; Walker JR; Smith MJ
    Ann Rheum Dis; 1979 Jun; 38(3):219-21. PubMed ID: 485576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease?
    Vayá A; Ricart J; Todolí J; Micó L; Contreras T; Aznar J
    Clin Hemorheol Microcirc; 2004; 30(3-4):411-4. PubMed ID: 15258375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator activity levels in patients with Behçet's syndrome.
    Mishima H; Masuda K; Shimada S; Toki N; Tsushima H; Gocho M
    Arch Ophthalmol; 1985 Jul; 103(7):935-6. PubMed ID: 4040357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.